 ReviewMethodological considerations in the design of trials for safety assessment of new drugs and chemical entitiesCornel Pater  Cornel Pater, Hannover, Germany author email corresponding author email
Current Controlled Trials in Cardiovascular Medicine 2005,
6:1doi:10.1186/1468-6708-6-1
|
|
| Published: |
3 February 2005 |
First paragraph (this article has no abstract)
Assessment of the QT interval started to receive increased regulatory attention in the late 1980s. |